242 related articles for article (PubMed ID: 29103353)
1. Cyclodextrin-based oral dissolving films formulation of taste-masked meloxicam.
Samprasit W; Akkaramongkolporn P; Kaomongkolgit R; Opanasopit P
Pharm Dev Technol; 2018 Jun; 23(5):530-539. PubMed ID: 29103353
[TBL] [Abstract][Full Text] [Related]
2. Fast releasing oral electrospun PVP/CD nanofiber mats of taste-masked meloxicam.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Kaomongkolgit R; Opanasopit P
Int J Pharm; 2015 Jun; 487(1-2):213-22. PubMed ID: 25899284
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30.
El-Badry M; Fathy M
Drug Dev Ind Pharm; 2006 Feb; 32(2):141-50. PubMed ID: 16537195
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
Obaidat AA; Obaidat RM
Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
[TBL] [Abstract][Full Text] [Related]
6. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
[TBL] [Abstract][Full Text] [Related]
7. Fast-acting clotrimazole composited PVP/HPβCD nanofibers for oral candidiasis application.
Tonglairoum P; Ngawhirunpat T; Rojanarata T; Kaomongkolgit R; Opanasopit P
Pharm Res; 2014 Aug; 31(8):1893-906. PubMed ID: 24554117
[TBL] [Abstract][Full Text] [Related]
8. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
9. Fast Dissolving Oral Drug Delivery System Based on Electrospun Nanofibrous Webs of Cyclodextrin/Ibuprofen Inclusion Complex Nanofibers.
Celebioglu A; Uyar T
Mol Pharm; 2019 Oct; 16(10):4387-4398. PubMed ID: 31436100
[TBL] [Abstract][Full Text] [Related]
10. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability.
Radia O; Rogalska E; Moulay-Hassane G
Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700
[TBL] [Abstract][Full Text] [Related]
11. Development of meloxicam-loaded electrospun polyvinyl alcohol mats as a transdermal therapeutic agent.
Ngawhirunpat T; Opanasopit P; Rojanarata T; Akkaramongkolporn P; Ruktanonchai U; Supaphol P
Pharm Dev Technol; 2009; 14(1):70-9. PubMed ID: 18800295
[TBL] [Abstract][Full Text] [Related]
12. Bovine serum albumin-meloxicam nanoaggregates laden contact lenses for ophthalmic drug delivery in treatment of postcataract endophthalmitis.
Zhang W; Zu D; Chen J; Peng J; Liu Y; Zhang H; Li S; Pan W
Int J Pharm; 2014 Nov; 475(1-2):25-34. PubMed ID: 25158220
[TBL] [Abstract][Full Text] [Related]
13. Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies.
Yener G; Üner M; Gönüllü Ü; Yildirim S; Kiliç P; Aslan SS; Barla A
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1466-73. PubMed ID: 21048338
[TBL] [Abstract][Full Text] [Related]
14. pH-Responsive polymeric micelles based on amphiphilic chitosan derivatives: Effect of hydrophobic cores on oral meloxicam delivery.
Woraphatphadung T; Sajomsang W; Gonil P; Treetong A; Akkaramongkolporn P; Ngawhirunpat T; Opanasopit P
Int J Pharm; 2016 Jan; 497(1-2):150-60. PubMed ID: 26657271
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.
El-Maradny HA; Mortada SA; Kamel OA; Hikal AH
Acta Pharm; 2008 Dec; 58(4):455-66. PubMed ID: 19103579
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
Aghazadeh-Habashi A; Jamali F
Eur J Pharm Biopharm; 2008 Nov; 70(3):889-94. PubMed ID: 18715548
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of plai oil/2-hydroxypropyl-β-cyclodextrin inclusion complexes in polyvinylpyrrolidone (PVP) electrospun nanofibers for topical application.
Tonglairoum P; Chuchote T; Ngawhirunpat T; Rojanarata T; Opanasopit P
Pharm Dev Technol; 2014 Jun; 19(4):430-7. PubMed ID: 23651060
[TBL] [Abstract][Full Text] [Related]
18. Meloxicam taste-masked oral disintegrating tablet with dissolution enhanced by ion exchange resins and cyclodextrin.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
AAPS PharmSciTech; 2013 Sep; 14(3):1118-28. PubMed ID: 23835739
[TBL] [Abstract][Full Text] [Related]
19. Strategies for meloxicam delivery to and across the skin: a review.
Chen J; Gao Y
Drug Deliv; 2016 Oct; 23(8):3146-3156. PubMed ID: 26956920
[TBL] [Abstract][Full Text] [Related]
20. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
Jain SK; Gupta Y; Jain A; Amin S
Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
